Jenny Kobin | Head, Investor Relations |
George Lasezkay | President & Chief Executive Officer |
Thomas Ciulla | Chief Medical Officer |
Charles Deignan | Chief Financial Officer |
Liana Moussatos | Wedbush Securities |
Annabel Samimy | Stifel |
Esther Hong | Janney Montgomery Scott |
Boris Peaker | Cowen |
Serge Belanger | Needham and Company |
Ladies and gentlemen, thank you for standing by and welcome to the Clearside Biomedical Fourth Quarter 2019 Financial Results and Corporate Update Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] As a reminder, today's program may be recorded.
I would now like to introduce your host for today's program Jenny Kobin, Investor Relations.